UTAH MEDICAL PRODUCTS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31)
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) of $9.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2 · last filed 2015-03-12
- 2014-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) $9.00K.
- 2013-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) $8.00K.
- 2013-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) $6.00K.
- 2013-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) $5.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2013-01-31) |
|---|---|
| 2014-12-31 | $9.00K 10-K · filed 2015-03-12 |
| 2013-12-31 | $8.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $6.00K 10-Q · filed 2013-11-06 |
| 2013-06-30 | $5.00K 10-Q · filed 2013-11-06 |
| 2013-03-31 | $3.00K 10-Q · filed 2013-08-08 |
| 2012-09-30 | -$183.00K 10-Q · filed 2013-11-06 |
| 2012-06-30 | -$188.00K 10-Q · filed 2013-11-06 |
| 2012-03-31 | -$183.00K 10-Q · filed 2013-08-08 |
| 2011-12-31 | -$193.00K 10-K · filed 2014-03-12 |
| 2010-12-31 | -$190.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |